A detailed history of Trustcore Financial Services, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Trustcore Financial Services, LLC holds 34 shares of REGN stock, worth $25,731. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34
Previous 34 -0.0%
Holding current value
$25,731
Previous $23,000 4.35%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

BUY
$543.48 - $670.97 $18,478 - $22,812
34 New
34 $21,000
Q3 2018

Nov 09, 2018

SELL
$351.14 - $408.51 $3,160 - $3,676
-9 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$284.6 - $344.99 $2,561 - $3,104
9 New
9 $3,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.